Tandem Diabetes Care (TNDM) PT Raised to $140 at Piper Sandler
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts TNDM Hot Sheet
Price: $18.66 -2.35%
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 25 | New: 16
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 25 | New: 16
Join SI Premium – FREE
Piper Sandler analyst Matt O'Brien raised the price target on Tandem Diabetes Care (NASDAQ: TNDM) to $140.00 (from $132.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Bright Minds Biosciences Inc. (DRUG) PT Lowered to $107 at Baird amid partial clinical hold
- Quanta Services (PWR) PT Lowered to $760 at Jefferies
- Carter's (CRI) PT Lowered to $33 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
